Commonwealth Equity Services’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-44,720
Closed -$4K 2410
2016
Q3
$4K Buy
44,720
+1,220
+3% +$266 ﹤0.01% 2249
2016
Q2
$16K Hold
43,500
﹤0.01% 2212
2016
Q1
$17K Buy
43,500
+1,000
+2% +$412 ﹤0.01% 2174
2015
Q4
$17K Hold
42,500
﹤0.01% 2155
2015
Q3
$24K Sell
42,500
-40,000
-48% -$20.5K ﹤0.01% 2101
2015
Q2
$45K Buy
82,500
+2,000
+2% +$1.63K ﹤0.01% 2137
2015
Q1
$66K Hold
80,500
﹤0.01% 2098
2014
Q4
$64K Sell
80,500
-1,000
-1% -$914 ﹤0.01% 2015
2014
Q3
$83K Hold
81,500
﹤0.01% 1979
2014
Q2
$70K Buy
+81,500
New +$97.7K ﹤0.01% 1967

Other funds holding PVCT

Commonwealth Equity Services's PVCT Position: Q4 2016 in Review

Commonwealth Equity Services sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 44,720 shares — an estimated $4K sold.

Commonwealth Equity Services first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $83K in Q3 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

  • Commonwealth Equity Services reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
  • Commonwealth Equity Services sold 44,720 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $4K.
  • Commonwealth Equity Services first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
  • Commonwealth Equity Services's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $83K in Q3 2014.
  • 8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Commonwealth Equity Services's 13F filing for Q4 2016, filed 1 Feb 2017.